What is Genetic nose and cavum anomaly?
Genetic nose and cavum anomaly is a very rare condition classified under Orphanet code 435606. This is a broad category that refers to birth defects affecting the structure of the nose and the nasal cavity (cavum) that have a genetic basis. These anomalies can range from mild cosmetic differences to more significant structural problems that may affect breathing, smell, and facial appearance. The nose and nasal cavity play important roles in breathing, filtering air, and the sense of smell. When these structures do not develop properly due to genetic causes, a person may experience difficulty breathing through the nose, recurrent sinus infections, changes in the sense of smell, or visible differences in the shape or size of the nose. In some cases, these anomalies may occur as part of a broader genetic syndrome that affects other parts of the body as well. Treatment depends on the specific type and severity of the anomaly. Options may include surgical correction to improve both function and appearance, as well as supportive care such as managing breathing difficulties or recurrent infections. Because this is a grouping category rather than a single well-defined disease, the specific genetic cause, symptoms, and outlook can vary widely from person to person. A clinical geneticist can help determine the exact underlying cause and guide appropriate management.
Key symptoms:
Abnormal shape or size of the noseDifficulty breathing through the noseBlocked or narrow nasal passagesReduced or absent sense of smellRecurrent sinus infectionsVisible facial asymmetry involving the noseAbsent or underdeveloped nose (in severe cases)Noisy breathing or snoringFeeding difficulties in newborns due to nasal obstructionMouth breathing
- Inheritance
- Variable
- Can be inherited in different ways depending on the underlying gene
- Age of Onset
- Neonatal
- Begins at or shortly after birth (first 4 weeks)
Treatments
Source: openFDA + DailyMed · NDA / BLA labels with structured indications · refreshed weekly
No FDA-approved treatments are currently listed for Genetic nose and cavum anomaly.
View clinical trials →Clinical Trials
View all trials with filters →Source: ClinicalTrials.gov · synced daily · phases, status, and PI names normalized at ingest
No actively recruiting trials found for Genetic nose and cavum anomaly at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →Source: NPI Registry + PubMed · trial PI roles cross-referenced with ClinicalTrials.gov · ranked by match score (publications + PI activity + community signal)
No specialists are currently listed for Genetic nose and cavum anomaly.
Treatment Centers
8 centersSource: NORD Rare Disease Centers + NIH Undiagnosed Diseases Network (UDN) · centers verified active within last 12 months
Children's Hospital Colorado Rare Disease Program ↗
Children's Hospital Colorado
📍 Aurora, CO
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDBoston Children's Hospital Rare Disease Program ↗
Boston Children's Hospital
📍 Boston, MA
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
🏨 Children'sAnn & Robert H. Lurie Children's Hospital Genetics ↗
Lurie Children's Hospital
📍 Chicago, IL
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDCincinnati Children's Hospital Medical Center ↗
Cincinnati Children's
📍 Cincinnati, OH
👤 Boston Children's Hospital Rare Disease Program
🏨 Children'sNationwide Children's Hospital Rare Disease Center ↗
Nationwide Children's Hospital
📍 Columbus, OH
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
Travel Grants
No travel grants are currently matched to Genetic nose and cavum anomaly.
Community
No community posts yet. Be the first to share your experience with Genetic nose and cavum anomaly.
Start the conversation →Latest news about Genetic nose and cavum anomaly
Source: PubMed + NIH RePORTER + openFDA + clinical-journal RSS · last 30 days · disease-tagged at ingest by AI extraction with human QC
No recent news articles for Genetic nose and cavum anomaly.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What is the exact type of nasal anomaly my child has, and is it part of a broader genetic syndrome?,Should we pursue genetic testing to find the underlying cause?,Will my child need surgery, and if so, when is the best time to do it?,How will this condition affect my child's breathing, sense of smell, and overall development?,Are there risks that future children could have the same condition?,What specialists should be part of our care team?,What signs should prompt me to seek emergency care?
Common questions about Genetic nose and cavum anomaly
What is Genetic nose and cavum anomaly?
Genetic nose and cavum anomaly is a very rare condition classified under Orphanet code 435606. This is a broad category that refers to birth defects affecting the structure of the nose and the nasal cavity (cavum) that have a genetic basis. These anomalies can range from mild cosmetic differences to more significant structural problems that may affect breathing, smell, and facial appearance. The nose and nasal cavity play important roles in breathing, filtering air, and the sense of smell. When these structures do not develop properly due to genetic causes, a person may experience difficulty
At what age does Genetic nose and cavum anomaly typically begin?
Typical onset of Genetic nose and cavum anomaly is neonatal. Age of onset can vary across affected individuals.
Frequently asked questions about Genetic nose and cavum anomaly
Auto-generated from canonical disease facts (Orphanet, OMIM, ClinicalTrials.gov, openFDA, NPPES). Not a substitute for clinical guidance.
What is Genetic nose and cavum anomaly?
Genetic nose and cavum anomaly is a rare disease catalogued in international rare-disease ontologies (Orphanet ORPHA:435606). It is typically inherited as variable. Age of onset is generally neonatal. For verified primary sources, see the UniteRare Genetic nose and cavum anomaly page.
How is Genetic nose and cavum anomaly inherited?
Genetic nose and cavum anomaly follows variable inheritance. Genetic counseling is recommended for affected families to understand recurrence risk in offspring and the likelihood of unaffected siblings being carriers. Variants in the underlying gene(s) may be identified via clinical genetic testing.
Are there FDA-approved treatments for Genetic nose and cavum anomaly?
Approved treatments for Genetic nose and cavum anomaly are tracked from openFDA and DailyMed primary sources. Many rare diseases have no specific FDA-approved therapy; for those, supportive care and management of complications form the basis of clinical care. Orphan-drug-designation status is noted where applicable.
Are there clinical trials for Genetic nose and cavum anomaly?
Active clinical trials for Genetic nose and cavum anomaly are tracked daily from ClinicalTrials.gov. Trial availability changes frequently; check the UniteRare trial listings for the current count and recruitment status. Sponsors of rare-disease research often welcome inquiries even when a trial is not actively recruiting at a given moment.
How do I find a specialist for Genetic nose and cavum anomaly?
Verified Genetic nose and cavum anomaly specialists are identified through ClinicalTrials.gov principal-investigator records, peer-reviewed publication authorship (via PubMed), and the NPPES NPI registry. NORD-designated Centers of Excellence and NIH-affiliated rare-disease clinics are also tracked. UniteRare's specialist directory is updated continuously as new evidence becomes available.
See full Genetic nose and cavum anomaly page for complete clinical details, sources, and verified-specialist listings.
Cite this page
Select a citation format above to view and copy.